A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
Phase 2
100
about 8.1 years
18–70
1 site in TN
What this study is about
This trial is testing a treatment called lifileucel, which are tumor-infiltrating lymphocytes (TILs), in adults with advanced melanoma. This is a Phase 2 trial for participants who have previously received treatment for unresectable or metastatic melanoma.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Lifileucel
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
lifileucel
Primary: Objective Response Rate
Secondary: Adverse Events, Complete Response Rate, Disease Control Rate, Duration of Response, Objective Response Rate, Overall Survival, Progression-Free Survival
Oncology